SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-023084
Filing Date
2019-04-23
Accepted
2019-04-23 16:12:45
Documents
5
Effectiveness Date
2019-04-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2706_3defa14a.htm DEFA14A 31993
2 GRAPHIC g27063bci001.gif GRAPHIC 54896
3 GRAPHIC g27063bci002.gif GRAPHIC 89026
4 GRAPHIC g27063bci003.gif GRAPHIC 22478
5 GRAPHIC g27063bci004.gif GRAPHIC 3594
  Complete submission text file 0001104659-19-023084.txt   267677
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38129 | Film No.: 19761697
SIC: 2834 Pharmaceutical Preparations